Balyasny Asset Management LLC Sarepta Therapeutics, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 165,973 shares of SRPT stock, worth $11.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
165,973
Previous 60,000
176.62%
Holding current value
$11.9 Million
Previous $7.49 Million
169.28%
% of portfolio
0.03%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding SRPT
# of Institutions
534Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$741 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$652 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$625 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$311 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$292 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.29B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...